INTERACTION OF HYDRIDE Σ-COMPLEX OF 5,7-DINITRO-8-HYDROXYQUINOLINE WITH SALTS OF AROMATIC DIAZO COMPOUNDS

Interaction between 5,7-dinitro-8-hydroxyquinoline hydride anionic σ-adduct and chlorides of substituted aryldiazonium in water yielded 5-arylazo-7-nitro-8-hydroxyquinolines, the substitution products of the nitro group at the C-5 σ-adduct position. The direction of the reaction agrees with the quantum-chemical calculations carried out earlier and the GMLA principle, which assumes that the mild acid, which is a diazocathione, will attack the reaction center to which the softest base corresponds, that is, the least negatively charged C-5 carbon atom, in contrast to the C-7 atom. It is shown that the yield of the product increases with the presence of an electron-withdrawing substituent in the diazocomponent. Also in this study, the synthesis of the hydride σ-adduct of 5,7-dinitro-8-hydroxyquinoline was optimized. It was found that the use of pure dimethylacetamide as a solvent, as well as the addition of sodium carbonate, increases the yield and purity of the synthesized σ-adduct. The structure of the obtained compounds was proved by the methods of NMR and IR spectroscopy. In the IR spectra of all synthesized azo compounds, weak absorption bands corresponding to the stretching vibrations of the azogroup (N = N) are fixed in the range of 1400-1465 cm-1, which also indirectly confirms the expected direction of the reaction. Otherwise, the bands of the azogroup vibrations would be shifted to the 1500-1600 cm-1 region as a result of azo-hydrazoic tautomerism. In 1H NMR spectra of synthesized compounds, there is no proton signal of intramolecular hydrogen bond at δ 14-15 ppm, characteristic of the hydrazine form. The proton signals of the arylazo group also confirm the presence of the latter. The use of anionic hydride σ-complexes of dinitroquinoline derivatives as azo-component in the reaction with aromatic diazo compound expands the synthetic possibilities of the azo coupling reaction and allows to obtaine new nitroazoquinolines.